FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965536242> ?p ?o ?g. }

• W1965536242 endingPage "27" @default.
• W1965536242 startingPage "21" @default.
• W1965536242 abstract "Cannabinoids have long been shown to have a range of potential therapeutic effects, including antiemetic actions, analgesia, and anxiolysis. However, psychomimetic and memory disruptive side effects, as well as the potential for abuse and dependence, have restricted their clinical development. Endogenous cannabinoids (i.e., endocannabinoids; eCBs), such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG), are produced throughout the limbic system and other brain regions associated with emotionality and are believed to modulate behavioral responses to stress-related conditions. AEA and 2-AG are rapidly metabolized by the respective enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). Accordingly, inhibition of each enzyme increases brain levels of the appropriate eCB. Although FAAH inhibition has been established to decrease anxiety-like behavior, the role of 2-AG has been difficult to ascertain until the recent synthesis of JZL184, a potent and selective MAGL inhibitor. In the present study, we investigated the effects of inhibiting FAAH or MAGL on anxiety-like behavior in marble burying, a model of repetitive, compulsive behaviors germane to anxiety disorders such as obsessive-compulsive disorder. The FAAH inhibitor PF-3845, the MAGL inhibitor JZL184, and the benzodiazepine diazepam decreased marble burying at doses that did not affect locomotor activity. In contrast, Δ9-tetrahydrocannabinol (THC), the primary psychoactive constituent of marijuana, did not consistently reduce marble burying without also eliciting profound decreases in locomotor behavior. The CB1 cannabinoid receptor antagonist rimonabant blocked the reduction in marble burying caused by FAAH and MAGL inhibitors, but not by diazepam, indicating a CB1 receptor mechanism of action. These data indicate that elevation of AEA or 2-AG reduces marble burying behavior and suggest that their catabolic enzymes represent potential targets for the development of new classes of pharmacotherapeutics to treat anxiety-related disorders." @default.
• W1965536242 created "2016-06-24" @default.
• W1965536242 creator A5009465292 @default.
• W1965536242 creator A5022995099 @default.
• W1965536242 creator A5035266773 @default.
• W1965536242 creator A5054637908 @default.
• W1965536242 creator A5058231328 @default.
• W1965536242 date "2011-03-01" @default.
• W1965536242 modified "2023-10-13" @default.
• W1965536242 title "Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay" @default.
• W1965536242 cites W1579700485 @default.
• W1965536242 cites W1836729582 @default.
• W1965536242 cites W1969338731 @default.
• W1965536242 cites W1980028866 @default.
• W1965536242 cites W1989073099 @default.
• W1965536242 cites W1996278273 @default.
• W1965536242 cites W2002355116 @default.
• W1965536242 cites W2003594380 @default.
• W1965536242 cites W2007924093 @default.
• W1965536242 cites W2012266823 @default.
• W1965536242 cites W2018723047 @default.
• W1965536242 cites W2018797949 @default.
• W1965536242 cites W2022305864 @default.
• W1965536242 cites W2024653583 @default.
• W1965536242 cites W2045165986 @default.
• W1965536242 cites W2049984492 @default.
• W1965536242 cites W2050022483 @default.
• W1965536242 cites W2051554315 @default.
• W1965536242 cites W2053714798 @default.
• W1965536242 cites W2056188558 @default.
• W1965536242 cites W2057355532 @default.
• W1965536242 cites W2062286606 @default.
• W1965536242 cites W2072316081 @default.
• W1965536242 cites W2075894678 @default.
• W1965536242 cites W2090705977 @default.
• W1965536242 cites W2093802594 @default.
• W1965536242 cites W2097822265 @default.
• W1965536242 cites W2101599025 @default.
• W1965536242 cites W2119826244 @default.
• W1965536242 cites W2120230768 @default.
• W1965536242 cites W2126187943 @default.
• W1965536242 cites W2132380973 @default.
• W1965536242 cites W2141551684 @default.
• W1965536242 cites W2141753787 @default.
• W1965536242 cites W2144303759 @default.
• W1965536242 cites W2162244350 @default.
• W1965536242 cites W2164973029 @default.
• W1965536242 cites W4241363254 @default.
• W1965536242 doi "https://doi.org/10.1016/j.pbb.2010.12.002" @default.
• W1965536242 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3034086" @default.
• W1965536242 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21145341" @default.
• W1965536242 hasPublicationYear "2011" @default.
• W1965536242 type Work @default.
• W1965536242 sameAs 1965536242 @default.
• W1965536242 citedByCount "146" @default.
• W1965536242 countsByYear W19655362422012 @default.
• W1965536242 countsByYear W19655362422013 @default.
• W1965536242 countsByYear W19655362422014 @default.
• W1965536242 countsByYear W19655362422015 @default.
• W1965536242 countsByYear W19655362422016 @default.
• W1965536242 countsByYear W19655362422017 @default.
• W1965536242 countsByYear W19655362422018 @default.
• W1965536242 countsByYear W19655362422019 @default.
• W1965536242 countsByYear W19655362422020 @default.
• W1965536242 countsByYear W19655362422021 @default.
• W1965536242 countsByYear W19655362422022 @default.
• W1965536242 countsByYear W19655362422023 @default.
• W1965536242 crossrefType "journal-article" @default.
• W1965536242 hasAuthorship W1965536242A5009465292 @default.
• W1965536242 hasAuthorship W1965536242A5022995099 @default.
• W1965536242 hasAuthorship W1965536242A5035266773 @default.
• W1965536242 hasAuthorship W1965536242A5054637908 @default.
• W1965536242 hasAuthorship W1965536242A5058231328 @default.
• W1965536242 hasBestOaLocation W19655362422 @default.
• W1965536242 hasConcept C148001335 @default.
• W1965536242 hasConcept C170493617 @default.
• W1965536242 hasConcept C185592680 @default.
• W1965536242 hasConcept C2776433454 @default.
• W1965536242 hasConcept C2776885963 @default.
• W1965536242 hasConcept C2777765862 @default.
• W1965536242 hasConcept C2779783865 @default.
• W1965536242 hasConcept C2780100140 @default.
• W1965536242 hasConcept C2780871563 @default.
• W1965536242 hasConcept C2781144285 @default.
• W1965536242 hasConcept C46721173 @default.
• W1965536242 hasConcept C55493867 @default.
• W1965536242 hasConcept C71924100 @default.
• W1965536242 hasConcept C8051207 @default.
• W1965536242 hasConcept C98274493 @default.
• W1965536242 hasConceptScore W1965536242C148001335 @default.
• W1965536242 hasConceptScore W1965536242C170493617 @default.
• W1965536242 hasConceptScore W1965536242C185592680 @default.
• W1965536242 hasConceptScore W1965536242C2776433454 @default.
• W1965536242 hasConceptScore W1965536242C2776885963 @default.
• W1965536242 hasConceptScore W1965536242C2777765862 @default.
• W1965536242 hasConceptScore W1965536242C2779783865 @default.
• W1965536242 hasConceptScore W1965536242C2780100140 @default.
• W1965536242 hasConceptScore W1965536242C2780871563 @default.

• next